How to Give 2000 mg Metformin Extended-Release
Administer metformin extended-release 2000 mg as a single dose once daily with the evening meal, ensuring the patient has an eGFR ≥30 mL/min/1.73 m² before initiation. 1
Dosing Schedule
- Give 2000 mg once daily with dinner or at bedtime 1
- The extended-release formulation achieves peak levels in 4-8 hours (median 7 hours), allowing for convenient once-daily dosing 1
- The 2000 mg once-daily dose provides equivalent total drug exposure (AUC) to immediate-release metformin 1000 mg twice daily 1
Titration Approach
Do not start at 2000 mg. The FDA label specifies gradual dose escalation to minimize gastrointestinal side effects 1:
- Start at 500 mg once daily with evening meal
- Increase by 500 mg weekly based on glycemic control and tolerability
- Maximum dose is 2000 mg once daily for extended-release formulation
The extended-release formulation significantly reduces GI adverse events compared to immediate-release, particularly nausea during initial dosing 2.
Critical Renal Function Considerations
Check eGFR before prescribing and monitor regularly 3, 1:
eGFR-Based Dosing Algorithm:
- eGFR ≥60 mL/min/1.73 m²: Full dose up to 2000 mg daily permitted
- eGFR 45-59 mL/min/1.73 m²: 2000 mg daily acceptable, but monitor eGFR every 3-6 months 3
- eGFR 30-44 mL/min/1.73 m²: Reduce maximum dose to 1000 mg daily 3
- eGFR <30 mL/min/1.73 m²: Contraindicated—discontinue metformin 1
The 2022 ADA/KDIGO consensus emphasizes that metformin should be dose-reduced to 1000 mg daily when eGFR falls between 30-44 mL/min/1.73 m², and also considered for dose reduction in patients with eGFR 45-59 mL/min/1.73 m² who have comorbidities increasing lactic acidosis risk (heart failure, liver disease, conditions causing hypoperfusion) 3.
Administration Details
- Take with food: Food decreases absorption by 25% (AUC) and 40% (Cmax), which actually helps reduce GI side effects 1
- Swallow tablets whole: Do not crush, cut, or chew extended-release tablets
- Timing consistency: Evening dosing is preferred and should be consistent daily
Common Pitfalls to Avoid
- Starting at full dose: This dramatically increases GI intolerance. Always titrate gradually 1
- Ignoring renal function: Failure to check eGFR before prescribing or during follow-up is the primary cause of metformin-associated lactic acidosis 3
- Continuing during acute illness: Hold metformin during conditions causing dehydration, hypoxemia, or acute kidney injury 3
- Iodinated contrast procedures: Discontinue metformin at time of contrast imaging in patients with eGFR 30-60 mL/min/1.73 m² or those with liver disease, alcoholism, or heart failure. Restart only after confirming stable renal function 48 hours post-procedure 1
Monitoring Requirements
- eGFR monitoring frequency 3:
- Annually if eGFR ≥60 mL/min/1.73 m²
- Every 3-6 months if eGFR <60 mL/min/1.73 m²
- Vitamin B12 levels: Check periodically, as metformin increases deficiency risk 4
- Glycemic response: Assess A1C at 3 months to determine if additional therapy needed
The 2025 ADA Standards recommend metformin as foundation therapy for most patients with type 2 diabetes due to its proven cardiovascular and mortality benefits, safety profile, and low cost 4. However, the extended-release formulation at 2000 mg once daily provides superior tolerability while maintaining equivalent efficacy to divided-dose immediate-release formulations 5, 2.